Agenus
AGEN
NZ$7.94
Share price
5.91%
Change (1 day)
-71.06%
Change (1 year)
Categories
Agenus (AGEN) - Total assets
Total assets on the balance sheet as of March 2025 : NZ$0.32 Billion
According to Agenus 's latest financial reports the company's total assets are NZ$0.32 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Agenus - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | NZ$0.40 B | -19.17% |
| 2023-12-31 | NZ$0.49 B | -23.79% |
| 2022-12-31 | NZ$0.65 B | -4.52% |
| 2021-12-31 | NZ$0.68 B | 129.46% |
| 2020-12-31 | NZ$0.29 B | 28.9% |
| 2019-12-31 | NZ$0.23 B | 13.42% |
| 2018-12-31 | NZ$0.20 B | 4.35% |
| 2017-12-31 | NZ$0.19 B | -14.01% |
| 2016-12-31 | NZ$0.22 B | -35.96% |
| 2015-12-31 | NZ$0.35 B | 272.08% |
| 2014-12-31 | NZ$95.11 M | 124.38% |
| 2013-12-31 | NZ$42.39 M | 19.87% |
| 2012-12-31 | NZ$35.36 M | 39.35% |
| 2011-12-31 | NZ$25.37 M | -36.65% |
| 2010-12-31 | NZ$40.06 M | -36.57% |
| 2009-12-31 | NZ$63.15 M | -35.5% |
| 2008-12-31 | NZ$97.91 M | 68.41% |
| 2007-12-31 | NZ$58.14 M | -43.85% |
| 2006-12-31 | NZ$0.10 B | -32.04% |
| 2005-12-31 | NZ$0.15 B | -18.28% |
| 2004-12-31 | NZ$0.18 B | -13.47% |
| 2003-12-31 | NZ$0.21 B | 26.63% |
| 2002-12-31 | NZ$0.17 B | -24.46% |
| 2001-12-31 | NZ$0.22 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Merck MRK | NZ$188.91 B | 57,403.21% | 🇺🇸 USA |
 GlaxoSmithKline GSK | NZ$128.71 B | 39,078.78% | 🇬🇧 UK |
 Johnson & Johnson JNJ | NZ$317.81 B | 96,638.28% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | NZ$1.21 B | 269.36% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$151.67 B | 46,067.10% | 🇺🇸 USA |